ALBO   $44.175  0.54% Market Closed

Albireo Pharma Inc
Total Cash 222.48M
totalCashPerShare 10.747
EBITDA -122.81M
Total Debt 9.63M
quickRatio 5.936
currentRatio 6.315
Total Revenue 57.39M
debtToEquity 9.628
Revenue/Share 2.946
ROA -0.24941
ROE -0.93081003
grossProfits 39.22M
freeCashflow -73.51M
operatingCashflow -115.32M
earningsGrowth
revenueGrowth 1.683
grossMargins 0.95562
ebitdaMargins -2.13992
operatingMargins -2.14739
profitMargins -2.28511
enterpriseValue 701.12M
forwardPE -6.813272
floatShares 14.22M
sharesOutstanding 20.74M
sharesShort 553.91K
sharesShortPriorMonth 823.31K
dateShortInterest
sharesPercentSharesOut 0.03%
heldPercentInsiders 0.04%
heldPercentInstitutions 1.08%
Short Ratio help_outline 1.38%
shortPercentOfFloat 0.03%
impliedSharesOutstanding
bookValue 4.836
Price To Book help_outline 9.13
earningsQuarterlyGrowth
netIncomeToCommon -131.15M
trailingEps -6.66%
forwardEps -6.48%
enterpriseToEbitda -5.71
lastDividendValue
lastDividendDate
currentQuarterEstimate -1.97 4Q 2022
institutionsCount 161
lastUpdated April 22, 2023, 1:29 p.m.